AF IN HUMAN MYOCYTES

Effects of atrial fibrillation on the distribution and frequency of spontaneous calcium release events in human atrial myocytes

Coordinatore	CONSORCI INSTITUT CATALÀ DE CIÈNCIES CARDIOVASCULARS    more  Organization address address: Av. Sant Antoni M. Claret 167 city: Barcelona postcode: 8025 contact info Titolo: Dr. Nome: Leif Cognome: Hove-Madsen Email: send email Telefono: 34935565620 Fax: 34935565559
Nazionalità Coordinatore	Spain [ES]
Totale costo	166˙336 €
EC contributo	166˙336 €
Programma	FP7-PEOPLE Specific programme "People" implementing the Seventh Framework Programme of the European Community for research, technological development and demonstration activities (2007 to 2013)
Code Call	FP7-PEOPLE-2012-IEF
Funding Scheme	MC-IEF
Anno di inizio	2013
Periodo (anno-mese-giorno)	2013-04-02   -   2015-04-01

 Partecipanti

#	participant	country	role	EC contrib. [€]
1	Nome Ente NON disponibile  Organization address address: Av. Sant Antoni M. Claret 167 city: Barcelona postcode: 8025 contact info Titolo: Dr. Nome: Leif Cognome: Hove-Madsen Email: send email Telefono: 34935565620 Fax: 34935565559	ES (Barcelona)	coordinator	166˙336.20

Mappa

 Word cloud

Esplora la "nuvola delle parole (Word Cloud) per avere un'idea di massima del progetto.

 Obiettivo del progetto (Objective)

'Atrial fibrillation (AF) is the most common cardiac arrhythmia and currently there are no efficient treatments. The host laboratory has linked AF to abnormal Ca2 handling by increased spontaneous sarcoplasmic reticulum (SR) Ca2 release in human atrial myocytes (HAMs), and that an underlying mechanism is an increased expression and activation of A2A receptors. We hypothesize that the spatial distribution and frequency of spontaneous Ca2 releases are altered in myocytes from patients with AF because of changes in the activity and distribution of the SR Ca2 release channel (RyR2) or in proteins that modulate its activity. Then, the project has four aims: Spatial remodelling of spontaneous Ca2 release in AF; Distribution of proteins that modulate RyR2 activity in AF; Role of adenosine receptor heteromerization in AF; and Adenosine receptor-mediated modulation of the electrical signal. To do that we shall use: Fast confocal to determine if AF is associated with changes in the spatial distribution of spontaneous Ca2 release sites; Immunofluorescent labeling, confocal and fluorescence lifetime imaging (FLIM) to detect spatial changes in the RyR2distribution; Westernblot, IP and bimolecular fluorescence complementation to determine expression and heteromerization of A1-A2A in HAMs from patients with and without AF; and the effects of adenosine receptor heteromerization on [Ca2]i handling shall be visualized in cultured atrial HL-1 myocytes using bimolecular fluorescent complementation and fast confocal simultaneously. Patch-clamp shall be used to quantify corresponding changes in ICa,L, Ca2 content of the SR and frequency of spontaneous INCX. This study will allows us the identification of changes in the distribution of RyR2 or proteins that modulate its activity as a novel mechanism that potentiates the arrhythmogenic effect of spontaneous Ca2 release and to elucidate the role of A1-A2A receptor heterodimers to abnormal Ca2 handling in patients with AF.'